首页 产品中心
  • LGK-974

    • LGK974, LGK 974, NVP-LGK974
    货号: abs811224
    CAS号: 1243244-14-5
    分子式: C23H20N6O
    分子量: 396.44
    产品说明书
    分享:
    货号-规格 货期 价格 数量
    abs811224-5mg 现货 ¥1377.00
    - +
    abs811224-10mg 现货 ¥2305.00
    - +
    abs811224-50mg 现货 ¥6738.00
    - +
    大包装询价
    产品描述
    描述

    LGK974 is a highly potent, selective and orally bioavailable Porcupine inhibitor (Wnt signaling antagonist) with an IC50 <1 nM in the Wnt signaling reporter assay and Porcupine binding assay.

    纯度
    >98%
    储存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    别名
    LGK974, LGK 974, NVP-LGK974
    可溶性/溶解性
    DMSO Solubility: 79 mg/mL warmed (199.27 mM)
    生物活性
    靶点
    Porcn
    In vitro(体外研究)
    LGK974 effectively displaces -GNF-1331 with IC50 of 1 nM in the PORCN radioligand binding assay, and shows no major cytotoxicity in cells up to 20 µM. LGK974 shows comparable inhibitory activities against all tested Wnts with IC50 ranging from 0.05 to 2.4 nM, which is consistent with the genetic loss of PORCN phenotype. LGK974 specifically inhibits the growth of three RNF43-mutant cell lines, HPAF-II, PaTu 8988S, and Capan-2.
    In vivo(体内研究)
    In a murine MMTV-Wnt1 tumor model and a human head and neck squamous cell carcinoma model (HN30), LGK974 (3 mg/kg) inhibits Wnt signaling in vivo and induces tumor regression without significant body weight loss in the mice. LGK974 (5 mg/kg, p.o., BID) also inhibits tumor growth of RNF43-mutant pancreatic tumors (HPAF-II and Capan-2) in vivo.
    温馨提示:本产品仅作科研实验使用,不支持临床等研究
    • 实验方法 实验条件
      0张,还能上传 8 提交
          提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要提问”按钮填写您的疑问。
          提交不成功?请联系info@absin.cn。
          我要提问

      促销资讯 更多

        订购信息
        您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。
        GO
        • 0